12-hydroxyeicosatetraenoic acid

From NuGOwiki

Jump to: navigation, search

The NuGOwiki Metabolite Database is a joint initiative of NuGO and HMDB

Taxonomy Navigation Box; search by

All Metabolites | Biochemical | Nutritional | Functional | Metabolic Pathways | Diseases | Phenotypes | Physiological Processes | Protein

12-hydroxyeicosatetraenoic acid
2D structure for 12-hydroxyeicosatetraenoic acid
Chemical Name (5E,8Z,10Z,14Z)-12-hydroxyicosa-5,8,10,14-tetraenoic acid
Chemical Formula C20H32O3
CAS Number 71030-37-0
Chemical Information HMDB06111
Biochemical Taxonomy

  • Leukotrienes

Functional Taxonomy Not Available
Nutritional Taxonomy Not Available
Metabolic Pathways Not Available
Biofluid Location

  • Blood
  • Cerebrospinal Fluid (CSF)

Tissue Location Not Available
Normal Biofluid Concentrations

  • Blood: 0.79 +/- 0.24 umol/L
  • Cerebrospinal Fluid (CSF): 0.0 - 0.001 uM

Normal Tissue Concentrations Not Available
Diseases / Conditions Related to Nutrition

  • Symptomatic cerebral vasospasm

Other (Monogenic Disorders) Not Available
Abnormal Biofluid Concentrations

  • Cerebrospinal Fluid (CSF) (Symptomatic cerebral vasospasm): 0.068 +/- 0.23 uM

Abnormal Tissue Concentrations Not Available
Physiological Processes Not Available
Authors:
Affiliations:

Contents

Introduction

guidelines
12-hydroxyeicosatetraenoic acid (12-HETE) is an eicosanoid, a 5-lipoxygenase metabolite of arachidonic acid. 5-Lipoxygenase (LO)-derived leukotrienes are involved in inflammatory glomerular injury. LO product 12-HETE is associated with pathogenesis of hypertension, and may mediate angiotensin II and TGFbeta induced mesengial cell abnormality in diabetic nephropathy. 12-HETE is markedly elevated in the psoriatic lesions. 12-HETE is a vasoconstrictor eicosanoid that contribute to high blood pressure in (renovascular) hypertension and pregnancy-induced hypertension. A significant percentage of patients suffering from a selective increase in plasma LDL cholesterol (type IIa hyperlipoproteinaemia) exhibits increased platelet reactivity. This includes enhanced platelet responsiveness against a variety of platelet-stimulating agents ex vivo and enhanced arachidonic acid metabolism associated with increased generation of arachidonic acid metabolites such as 12-HETE, and secretion of platelet-storage products. (PMID: 7562532, 12480795, 17361113, 8498970, 1333255, 2119633)

Biological Function

guidelines

Catabolism

guidelines

Diseases / Conditions Related to Nutrition

guidelines

  • Symptomatic cerebral vasospasm

Other (Monogenic) Disorders

guidelines


Nutritional Information

guidelines

Drivers for biological variation

guidelines

Vulnerable groups

guidelines

Other resources

guidelines

Links

guidelines